MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.

MLA

Liu, Xuerong, et al. “MicroRNA-337 Inhibits Colorectal Cancer Progression by Directly Targeting KRAS and Suppressing the AKT and ERK Pathways.” Oncology Reports, vol. 48, no. 4, Oct. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3892/or.2022.8394.

APA

Liu, X., Wang, Y., & Zhao, J. (2022). MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways. Oncology Reports, 48(4), N.PAG. https://doi.org/10.3892/or.2022.8394

Chicago

Liu, Xuerong, Yan Wang, and Jinglong Zhao. 2022. “MicroRNA-337 Inhibits Colorectal Cancer Progression by Directly Targeting KRAS and Suppressing the AKT and ERK Pathways.” Oncology Reports 48 (4): N.PAG. doi:10.3892/or.2022.8394.